Howard Hughes Medical Institute’s Centene CNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-101
Closed -$4.16K 125
2025
Q4
$4.16K Hold
101
﹤0.01% 379
2025
Q3
$3.6K Sell
101
-6
-6% -$181 ﹤0.01% 399
2025
Q2
$5.81K Buy
+107
New +$6.28K ﹤0.01% 295
2017
Q3
Sell
-7,656
Closed -$306K 50
2017
Q2
$306K Buy
7,656
+2,286
+43% +$86.3K 0.06% 111
2017
Q1
$191K Buy
5,370
+2,640
+97% +$88.4K 0.04% 115
2016
Q4
$77K Buy
2,730
+1,248
+84% +$36.8K 0.02% 136
2016
Q3
$50K Buy
+1,482
New +$51.5K 0.01% 144
2014
Q4
Sell
-2,152
Closed -$44K 171
2014
Q3
$44K Buy
+2,152
New +$41.5K 0.01% 163

Other funds holding CNC

Howard Hughes Medical Institute's CNC Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Centene (CNC) in Q1 2026, closing a stake of 101 shares — an estimated $4.16K sold.

Howard Hughes Medical Institute first reported a position in CNC in Q3 2014 and held it in 8 quarters. The position peaked at $306K in Q2 2017. 864 funds tracked by Wall St. Rank hold CNC as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Centene position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 101 Centene shares in Q1 2026, an estimated $4.16K.
  • Howard Hughes Medical Institute first reported a position in Centene in Q3 2014 and held it in 8 quarters.
  • Howard Hughes Medical Institute's Centene position peaked at $306K in Q2 2017.
  • 864 funds tracked by Wall St. Rank held Centene as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.